Blog
Big News! FDA Approves Magstim Transcranial Magnetic Stimulation (TMS) System to Treat Major Depressive Disorder (MDD) in Teens
- March 4, 2025
-
NeuroMod Health
A Breakthrough in Mental Health Care for Adolescents
NeuroMod Health is pleased to share groundbreaking news in the field of mental health treatment: The U.S. Food and Drug Administration (FDA) has granted clearance for Magstim Horizon 3.0 and Horizon Inspire Transcranial Magnetic Stimulation (TMS) systems for the treatment of Major Depressive Disorder (MDD) in adolescent patients aged 15-21. This milestone expands the reach of non-invasive and effective treatment options, offering new hope to younger individuals struggling with depression.
Recent Posts
Advancing Adolescent Mental Health Care
The approval of the Horizon Inspire and Horizon 3.0 TMS systems marks a significant step forward in the treatment of adolescent depression. TMS is a non-invasive therapy that uses targeted magnetic pulses to stimulate areas of the brain associated with mood regulation, providing an alternative to traditional treatments such as medication and therapy.
For providers using Magstim technology, this clearance enables the treatment of adolescent patients with MDD, enhancing the accessibility of innovative mental health solutions tailored to younger individuals. Clinicians treating adolescent patients will need an updated Instructions for Use (IFU), which will be distributed accordingly.
The Importance of Innovation in Mental Health Treatment
Adolescence is a critical period of development, and mental health challenges during this stage can have lasting impacts. Traditional depression treatments may not always be effective or well-tolerated by younger patients, making alternative therapies like TMS essential in expanding available options. By delivering precise, individualized care, Horizon Inspire and Horizon 3.0 provide a safe and effective alternative that supports long-term well-being.
Shaping the Future of Mental Health Care
This FDA clearance reinforces the importance of advancing mental health solutions that cater to diverse patient needs. As more adolescents gain access to cutting-edge treatments like TMS, we move closer to transforming the landscape of mental health care and improving outcomes for younger generations.
NeuroMod Health remains committed to offering the latest advancements in TMS therapy and supporting clinicians in providing life-changing treatments for patients of all ages.
For more information on how Magstim TMS systems can support adolescent mental health treatment, contact us today.
